Open access · OA
via OpenAlex
Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool
Javier García-Castro, César Trigueros, Joaquín Madrenas, José Antonio Pérez‐Simón, René Rodríguez, Pablo R. Menéndez
Journal of Cellular and Molecular Medicine · 2008 · ▲ 150 citations
Abstract
Introduction Mechanisms of immunological tolerance MSCs and cell replacement strategies Clinical applications based on MSCs immune modulatory properties: overview of ongoing clinical trials MSCs as a model to study cell transformation and disease Concluding remarks Abstract Mesenchymal stem cells (MSCs) from adult somatic tissues may differentiate in vitro and in vivo into multiple mesodermal tissues including bone, cartilage, adipose tissue, tendon, ligament or even muscle. MSCs preferentially home to damaged tissues where they exert their therapeutic potential. A striking feature of the MSCs is their low inherent immunogenicity as they induce little, if any, proliferation of allogeneic lymphocytes and antigen‐presenting cells. Instead, MSCs appear to be immunosuppressive in vitro. Their multi‐lineage differentiation potential coupled to their immuno‐privileged properties is being exploited worldwide for both autologous and allo‐geneic cell replacement strategies. Here, we introduce the readers to the biology of MSCs and the mechanisms underlying immune tolerance. We then outline potential cell replacement strategies and clinical applications based on the MSCs immunological properties. Ongoing clinical trials for graft‐versus‐host‐disease, haematopoietic recovery after co‐transplantation of MSCs along with haematopoietic stem cells and tissue repair are discussed. Finally, we review the emerging area based on the use of MSCs as a target cell subset for either spontaneous or induced neoplastic transformation and, for modelling non‐haematological mesenchymal cancers such as sarcomas.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/j.1582-4934.2008.00516.x
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
García-Castro, J., Trigueros, C., Madrenas, J., Pérez‐Simón, J.A., Rodríguez, R., & Menéndez, P.R. (2008). Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool. <em>Journal of Cellular and Molecular Medicine</em>. https://doi.org/10.1111/j.1582-4934.2008.00516.x
Vancouver
García-Castro J, Trigueros C, Madrenas J, Pérez‐Simón JA, Rodríguez R, Menéndez PR. Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool. Journal of Cellular and Molecular Medicine. 2008. doi:10.1111/j.1582-4934.2008.00516.x.
BibTeX
@article{javier2008Mesenc,
title = {Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool},
author = {Javier García-Castro and César Trigueros and Joaquín Madrenas and José Antonio Pérez‐Simón and René Rodríguez and Pablo R. Menéndez},
journal = {Journal of Cellular and Molecular Medicine},
year = {2008},
doi = {10.1111/j.1582-4934.2008.00516.x},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Internal Medicine 2007
Open access · OA
Immunomodulation by mesenchymal stem cells and clinical experience
Basic & Clinical Pharmacology & Toxicology 2004
Open access · OA
Mesenchymal Stem Cells: Cell Biology and Potential Use in Therapy
Biotechnology Advances 2013
Open access · CC-BY
Application of human mesenchymal and pluripotent stem cell microcarrier cultures in cellular therapy: Achievements and future direction
Blood Cancer Journal 2014
Open access · CC-BY
Induced pluripotent stem cells in hematology: current and future applications
Stem Cell Research & Therapy 2020
Open access · CC-BY
Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress
Arthritis Research 2003
Open access · OA